Latest Biotech News

A collaborative team from UMC Utrecht and Utrecht University developed GRACE, an AI-enhanced volumetric bioprinting technology revolutionizing tissue engineering. This method integrates real-time...

Recent breakthroughs in cancer treatment highlight the integration of oncolytic viruses (OVs) with immunotherapy, offering new avenues by selectively targeting and lysing tumor cells while...

New insights into cancer progression and immune evasion have emerged, including discoveries of innate immune checkpoint inhibitors showing efficacy against solid tumors in preclinical models and...

The FDA has committed to unprecedented transparency by publicly releasing complete response letters (CRLs) in real time upon issuance, alongside disclosures of previously unpublished CRLs related...

The biotech investment landscape shows signs of resilience, with prominent venture capital firms like Atlas Venture raising substantial opportunity funds — $400 million in its latest round — to...

Advanced single-cell and spatial transcriptomics studies have deepened understanding of brain aging and neurodegenerative conditions such as Alzheimer’s disease and Lewy body dementia. Noteworthy...

Pioneering efforts in gene and cell therapies have yielded transformative outcomes for rare diseases, exemplified by the first FDA-approved islet cell transplant using Lantidra for Type 1 diabetes...

The integration of artificial intelligence and machine learning technologies is markedly accelerating discovery and development in biotech. Breakthroughs include the creation of AI-driven...

Significant collaborations and licensing agreements are reshaping therapeutic landscapes, highlighted by Novartis’ $200 million collaboration with Arrowhead Pharmaceuticals to develop RNAi...

Bioprocessing advancements are driving efficiency and scalability in drug manufacturing, particularly for complex modalities such as cell and gene therapies. Industry leaders emphasize the...

Tensions persist around vaccine policy and public health governance in the United States, marked by sharp divides between federal and state authorities. Recent upheavals within the Centers for...

The U.S. Food and Drug Administration (FDA) has initiated a groundbreaking policy to publish complete response letters (CRLs), commonly known as drug rejection letters, concurrently with their...

Novartis has entered a significant partnership with Arrowhead Pharmaceuticals, investing $200 million upfront to license and develop RNA interference (RNAi) therapies targeting Parkinson’s disease...

Radiance Biopharma, a relatively new biotech founded two years ago, has inked a global licensing agreement with Novatim Immune Therapeutics for a bispecific nanobody antibody-drug conjugate (ADC)...

Clinicians at the University of Nebraska’s Fred & Pamela Buffett Cancer Center administered a pioneering allogeneic CAR T-cell therapy, azercabtagene zapreleucel (azer-cel), to a 49-year-old...

Researchers from the University of Illinois Urbana-Champaign unveiled oPool+ display, a revolutionary high-throughput platform that integrates oligo pool synthesis with mRNA display to rapidly...

The London-based biotech Charm Therapeutics secured an $80 million Series B financing round, co-led by New Enterprise Associates and DR One, to push forward clinical development of its...

Regenxbio presented promising one-year follow-up data for its gene therapy targeting Hunter syndrome, a rare lysosomal storage disorder characterized by iduronate-2-sulfatase deficiency. The data,...

Researchers from UMC Utrecht and Utrecht University developed GRACE, a cutting-edge volumetric bioprinting workflow combining artificial intelligence, advanced imaging, and context-aware printing....

Atlas Venture, a prominent biotech investment firm, secured $400 million for its third Opportunity Fund dedicated to backing biopharma companies within its existing portfolio. This strategic...